Similar Papers

Paper Title
Journal
Date
Author
Clinical effect of lumacaftor/ivacaftor in F508del homozygous CF patients with FEV1 ≥ 90% predicted at baseline
B.L Aalbers ... H.G.M Heijerman
Journal of Cystic Fibrosis | VOL. 19
B.L Aalbers, et. al.B.L Aalbers ... H.G.M Heijerman
07 Jan 2020
Personalized CFTR Modulator Therapy for G85E and N1303K Homozygous Patients with Cystic Fibrosis.
Simon Y Graeber ... Jobst Röhmel
International Journal of Molecular Sciences | VOL. 24
Simon Y Graeber, et. al.Simon Y Graeber ... Jobst Röhmel
02 Aug 2023
Longitudinal changes in lung function following initiation of lumacaftor/ivacaftor combination
Ioanna Loukou ... Konstantinos Douros
Journal of Cystic Fibrosis | VOL. 19
Ioanna Loukou, et. al.Ioanna Loukou ... Konstantinos Douros
30 Oct 2019
Elexacaftor/tezacaftor/ivacaftor-real-world clinical effectiveness and safety. A single-center Portuguese study.
Kelly Lopes ... Pilar Azevedo
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia | VOL. 49
Kelly Lopes, et. al.Kelly Lopes ... Pilar Azevedo
03 Feb 2023
View more papers

More From: Journal of Cystic Fibrosis

Paper Title
Journal
Date
Author
Real-world association between ivacaftor initiation and lung function variability: A registry study
Rhonda D Szczesniak ... Wayne J Morgan
Journal of Cystic Fibrosis | VOL. -
Rhonda D Szczesniak, et. al.Rhonda D Szczesniak ... Wayne J Morgan
01 Feb 2025
News article
-
Journal of Cystic Fibrosis | VOL. -
--
01 Jan 2025
Lung-kidney axis in cystic fibrosis: Early urinary markers of kidney injury correlate with neutrophil activation and worse lung function
Grace M Rosner ... Sladjana Skopelja-Gardner
Journal of Cystic Fibrosis | VOL. -
Grace M Rosner, et. al.Grace M Rosner ... Sladjana Skopelja-Gardner
01 Jan 2025
Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment
Edith T Zemanick ... Nicole Mayer-Hamblett
Journal of Cystic Fibrosis | VOL. -
Edith T Zemanick, et. al.Edith T Zemanick ... Nicole Mayer-Hamblett
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.